Compare CVRX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVRX | SENS |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.0M | 225.5M |
| IPO Year | 2021 | N/A |
| Metric | CVRX | SENS |
|---|---|---|
| Price | $7.31 | $7.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $13.17 | ★ $25.58 |
| AVG Volume (30 Days) | 371.4K | ★ 449.6K |
| Earning Date | 02-04-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,969,000.00 | $29,298,000.00 |
| Revenue This Year | $11.91 | $59.55 |
| Revenue Next Year | $15.28 | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.44 | ★ 31.94 |
| 52 Week Low | $4.30 | $5.25 |
| 52 Week High | $17.78 | $28.00 |
| Indicator | CVRX | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 54.79 |
| Support Level | $6.96 | $6.98 |
| Resistance Level | $6.09 | $7.74 |
| Average True Range (ATR) | 0.81 | 0.48 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 60.17 | 35.90 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.